Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 4, Pages 801
Publisher
MDPI AG
Online
2021-02-17
DOI
10.3390/jcm10040801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient
- (2021) Atefeh Fakharian et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- Covid-19: Arthritis drugs improve survival in intensive care patients, shows study
- (2021) Jacqui Wise BMJ-British Medical Journal
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
- (2020) Yongshi Yang et al. JOURNAL OF AUTOIMMUNITY
- Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
- (2020) Sufang Tian et al. Journal of Thoracic Oncology
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Preconditioning rats with three lipid emulsions prior to acute lung injury affects cytokine production and cell apoptosis in the lung and liver
- (2020) Li-Mi Huang et al. Lipids in Health and Disease
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- COVID-19, ACE2, and the cardiovascular consequences
- (2020) Andrew M. South et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Nervous system involvement after infection with COVID-19 and other coronaviruses
- (2020) Yeshun Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019
- (2020) Yuan-Yuan Qin et al. CHINESE MEDICAL JOURNAL
- Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
- (2020) Jie Ma et al. CLINICAL IMMUNOLOGY
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
- (2020) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
- (2020) Francesco Bennardo et al. ORAL ONCOLOGY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
- (2020) Alfonso J. Rodriguez-Morales et al. Travel Medicine and Infectious Disease
- Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
- (2020) Sebastiano Cicco et al. MEDIATORS OF INFLAMMATION
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical Parameters
- (2020) Christine Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockage of interleukin-1β with canakinumab in patients with Covid-19
- (2020) Lorenza Landi et al. Scientific Reports
- Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response
- (2019) Abhishek Mohanty et al. Journal of Cell Communication and Signaling
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Innate immune memory: An evolutionary perspective
- (2018) Benjamin Gourbal et al. IMMUNOLOGICAL REVIEWS
- Melatonin: A Versatile Protector against Oxidative DNA Damage
- (2018) Annia Galano et al. MOLECULES
- Mitochondria in innate immune signaling
- (2018) Balaji Banoth et al. Translational Research
- Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
- (2017) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain
- (2017) James A Letts et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain
- (2017) James A Letts et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
- (2015) S. Yokota et al. JOURNAL OF RHEUMATOLOGY
- Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
- (2013) Tom W J Huizinga et al. ANNALS OF THE RHEUMATIC DISEASES
- Advances in understanding the pathogenesis of HLH
- (2013) G. Naheed Usmani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy*
- (2012) David T. Selewski et al. CRITICAL CARE MEDICINE
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started